Clinical Trials Browser

Prostatic Neoplasms

NCT05732948 2023-11-29

PD-1 Silent PSMA/PSCA Targeted CAR-T for the Treatment of Prostate Cancer

Phase 1 Unknown

12 enrolled

Genitourinary

Prostatic Neoplasms

NCT05580107 2023-11-07

MDPK67b in Patients With Prostate Cancer

Phase 1 Unknown

15 enrolled

Genitourinary

Prostatic Neoplasms

NCT06065592 2023-10-06

CAT_PB

Phase 1 Unknown

500 enrolled

BreastGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Cardiovascular Diseases, Colonic Neoplasms, Carcinoma, Hepatocellular, Immune System Diseases, Inflammation, Lung Neoplasms, Neoplasms, Prostatic Neoplasms, Thromboembolism, Thrombosis

NCT06062355 2023-10-02

Phase I Clinical Study of HRS-9815 for PET/CT Imaging in Patients With Prostate Cancer

Phase 1 Unknown

9 enrolled

Genitourinary

Prostatic Neoplasms

NCT05902247 2023-06-13

225AcPSMAI&T

Phase 1 Unknown

30 enrolled

Genitourinary

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT05856630 2023-05-12

Pharmacokinetics Pharmacodynamics and Safety of LY01022 in Patients With Prostate Cancer Compared With Zoladex® 10.8mg

Phase 1 Unknown

24 enrolled

Genitourinary

Prostatic Neoplasms

NCT04768868 2023-02-24

WEE1

Phase 1 Unknown

350 enrolled

BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

NCT03934827 2022-08-11

MICROBIOME

Phase 1 Unknown

120 enrolled

BreastDermatologicGenitourinaryGynecologicHead & NeckThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Urethral Neoplasms, Uterine Neoplasms

NCT04783636 2021-03-17

To Compare the Safety and Pharmacokinetics of PT105 With PT105R in Healthy Postmenopausal Female Volunteers

Phase 1 Unknown

40 enrolled

Genitourinary

Prostatic Neoplasms

NCT04107142 2019-09-27

Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid Tumour

Phase 1 Unknown

10 enrolled

BreastGastrointestinalGenitourinaryHead & NeckSarcoma

Nasopharyngeal Carcinoma, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT02950064 2019-01-14

A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA Mutations

Phase 1 Unknown

95 enrolled

BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Triple Negative Breast Neoplasms

NCT02058680 2018-09-10

PSA

Phase 1 Unknown

48 enrolled

Genitourinary

Prostatic Neoplasms

NCT03098160 2017-10-30

Immunotherapy Study of Evofosfamide in Combination With Ipilimumab

Phase 1 Unknown

69 enrolled

DermatologicGastrointestinalGenitourinaryHead & Neck

Squamous Cell Carcinoma of Head and Neck, Hypoxia, Melanoma, Pancreatic Neoplasms, Prostatic Neoplasms

NCT03164837 2017-05-24

68Ga-NOTA-RM26 PET/CT in Prostate Cancer Patients

Phase 1 Unknown

30 enrolled

Genitourinary

Prostatic Neoplasms

NCT03029533 2017-01-24

Phase 1 Study to Evaluate the Pharmacokinetics and Safety Following SC Administration of DWJ108J in Patients With Prostate Cancer

Phase 1 Unknown

44 enrolled

Genitourinary

Prostatic Neoplasms

NCT02840617 2016-07-21

ICG-based Fluorescence Imaging in Localization of Prostate Cancer and Metastatic Lymph Nodes

Phase 1 Unknown

50 enrolled

Genitourinary

Prostatic Neoplasms

NCT02747563 2016-04-21

Evaluation of PSA Blood Levels Prior to and After Digital Rectal Examination

Phase 1 Unknown

60 enrolled

Genitourinary

Prostatic Neoplasms

NCT00969202 2015-11-18

Stereotactic Hypofractionated Radiosurgery for Early Stage Prostate Cancer

Phase 1 Unknown

50 enrolled

Genitourinary

Prostatic Neoplasms

NCT02233725 2014-09-08

MRI / Ultrasound Fusion With Contrast-Enhanced Ultrasound Guidance

Phase 1 Unknown

50 enrolled

Genitourinary

Prostatic Neoplasms

NCT00003633 2013-12-19

Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer

Phase 1 Unknown

12 enrolled

Genitourinary

Prostatic Neoplasms

NCT00024063 2013-12-19

SU006668 in Treating Patients With Advanced Solid Tumors

Phase 1 Unknown

BreastGastrointestinalGenitourinaryPlasma cellThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Kidney Neoplasms, Lung Neoplasms, Multiple Myeloma, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Breast Neoplasms, Male, Neoplasms, Plasma Cell

NCT00009750 2013-09-20